首页 > 市场调查报告书 > 製药

自体免疫疾病孤儿药

市场调查报告书

商品编码

1136966

干燥症(修格兰氏症候群)市场:药物(抗疟疾哇林药，胆碱促效剂，皮质类固醇，其他)，各类型，各流通管道，各地区-规模，占有率，展望，机会分析，2022年～2030年

Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年09月09日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

市场动态

预计干燥综合征患病率的增加将在预测期内推动市场增长。

本调查的主要特征

本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球干燥症(修格兰氏症候群)市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球干燥症(修格兰氏症候群)市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球干燥症(修格兰氏症候群)市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球干燥症(修格兰氏症候群)市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

Competitive Snapshot
- ADVANZ Pharma
Type Portfolio
- Bristol Myers Squibb
Type Portfolio
- Daiichi Sankyo
Type Portfolio
- GlaxoSmithKline
Type Portfolio
- Novartis/MorphoSys
Type Portfolio
- RemeGen
Type Portfolio
- Resolve Therapeutics
Type Portfolio
- TearSolutions
Type Portfolio
- VIELABIO
Type Portfolio
- Otsuka Pharmaceutical Co., Ltd.
Type Portfolio
- Bridge Pharma Inc.
Type Portfolio

第10章章节

参考文献
调查手法

简介目录

Product Code: CMI5210

Sjogren's syndrome is systematic autoimmune disorder which effect the entire body, along with complication such as, chronic pain, major organ involvement, profound fatigue, neuropathies and Sjogren's syndrome zmphomas.

For the treatment of Sjogren's syndrome different medication such as methotrexate available to manage the syndrome. Currently no single medication has been conclusively proven to treat the progression of Sjogren's.

Antimalarial Quinolines, Cholinergic Agonists and Corticosteroids are the prescription drug used for the treatment of Sjogren's.

Market Dynamics

Increasing prevalence of Sjogren's syndrome is expected to drive the market growth during the forecast period.

For instance, according to the Sjogren's Foundation 2021, around 3 to 4 million people in the U.S. suffer from Sjogren's syndrome which is as common as rheumatoid arthritis (RA), and three times as common as systemic lupus erythematosus (SLE).

Key features of the study:

This report provides an in-depth analysis of the global sjogren's syndrome market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sjogren's syndrome Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ADVANZ Pharma, Bristol Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Novartis/MorphoSys, RemeGen, Resolve Therapeutics, Tear Solutions, VIELABIO, Otsuka Pharmaceutical Co., Ltd., and Bridge Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sjogren's syndrome Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sjogren's syndrome Market

Detailed Segmentation:

Global Sjogren's Syndrome Market, By Drug:
- Antimalarial Quinolines
- Cholinergic Agonists
- Corticosteroids
- Others (Pain Relief Medication and late phase drug)
Global Sjogren's Syndrome Market, By Type:
- Primary
- Secondary
Global Sjogren's Syndrome Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Sjogren's Syndrome Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest Of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- ADVANZ Pharma *
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bristol Myers Squibb
- Daiichi Sankyo
- GlaxoSmithKline
- Novartis/MorphoSys
- RemeGen
- Resolve Therapeutics
- TearSolutions
- VIELABIO
- Otsuka Pharmaceutical Co., Ltd.
- Bridge Pharma Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Key Development Strategies
Mergers And Acquisition Scenario
Market Trends
Brand Analysis
Regulatory Scenario
PEST Analysis
Pricing Analysis
Pipeline Analysis

4. Global Sjogren's syndrome Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Impact on Manufacturing
Impact on Manufacturing

5. Global Sjogren's syndrome Market, By Drug, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Antimalarial Quinolines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Cholinergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others (Pain Relief Medication and late phase drug)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Sjogren's syndrome Market, By Type, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Primary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Secondary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Sjogren's syndrome Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Sjogren's syndrome Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
North America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

9. Competitive Landscape

Competitive Snapshot
- ADVANZ Pharma *
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Bristol Myers Squibb
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Daiichi Sankyo
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- GlaxoSmithKline
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Novartis/MorphoSys
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- RemeGen
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Resolve Therapeutics
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- TearSolutions
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- VIELABIO
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Otsuka Pharmaceutical Co., Ltd.
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies
- Bridge Pharma Inc.
Company Overview
Type Portfolio
Financial Overview
Key Highlights
Market Strategies

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

干燥症(修格兰氏症候群)市场:药物(抗疟疾哇林药，胆碱促效剂，皮质类固醇，其他)，各类型，各流通管道，各地区-规模，占有率，展望，机会分析，2022年～2030年

Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章调查目的与前提条件

第2章市场展望

第3章市场动态，法规，趋势分析

第4章干燥症(修格兰氏症候群)的全球市场:冠状病毒(COVID-19)疫情的影响

第5章干燥症(修格兰氏症候群)的全球市场:各药物，2017年～2030年

第6章干燥症(修格兰氏症候群)的全球市场:各类型，2017年～2030年

第7章干燥症(修格兰氏症候群)的全球市场:各流通管道，2017年～2030年

第8章干燥症(修格兰氏症候群)的全球市场:各地区，2017年～2030年

第9章竞争情形

第10章章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Sjogren's syndrome Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Sjogren's syndrome Market, By Drug, 2017 - 2030, (US$ Mn)

6. Global Sjogren's syndrome Market, By Type, 2017 - 2030, (US$ Mn)

7. Global Sjogren's syndrome Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

8. Global Sjogren's syndrome Market, By Region, 2017 - 2030, (US$ Mn)

9. Competitive Landscape

10. Section

干燥症(修格兰氏症候群)市场:药物(抗疟疾哇林药，胆碱促效剂，皮质类固醇，其他)，各类型，各流通管道，各地区-规模，占有率，展望，机会分析，2022年～2030年

Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章 调查目的与前提条件

第2章 市场展望

第3章 市场动态，法规，趋势分析

第4章 干燥症(修格兰氏症候群)的全球市场:冠状病毒(COVID-19)疫情的影响

第5章 干燥症(修格兰氏症候群)的全球市场:各药物，2017年～2030年

第6章 干燥症(修格兰氏症候群)的全球市场:各类型，2017年～2030年

第7章 干燥症(修格兰氏症候群)的全球市场:各流通管道，2017年～2030年

第8章 干燥症(修格兰氏症候群)的全球市场:各地区，2017年～2030年

第9章 竞争情形

第10章 章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Sjogren's syndrome Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Sjogren's syndrome Market, By Drug, 2017 - 2030, (US$ Mn)

6. Global Sjogren's syndrome Market, By Type, 2017 - 2030, (US$ Mn)

7. Global Sjogren's syndrome Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

8. Global Sjogren's syndrome Market, By Region, 2017 - 2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章调查目的与前提条件

第2章市场展望

第3章市场动态，法规，趋势分析

第4章干燥症(修格兰氏症候群)的全球市场:冠状病毒(COVID-19)疫情的影响

第5章干燥症(修格兰氏症候群)的全球市场:各药物，2017年～2030年

第6章干燥症(修格兰氏症候群)的全球市场:各类型，2017年～2030年

第7章干燥症(修格兰氏症候群)的全球市场:各流通管道，2017年～2030年

第8章干燥症(修格兰氏症候群)的全球市场:各地区，2017年～2030年

第9章竞争情形

第10章章节